Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05962619
Other study ID # AHAI
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date August 1, 2023
Est. completion date August 2, 2024

Study information

Verified date July 2023
Source Assiut University
Contact Ahmed Hussien, MBBH
Phone 01014417626
Email ahmed.s7s1929@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Comparison between Arthrocentesis alone arthrocentesis with hyaluronic acid injection in management of temporomandibular joint dysfunction in the form of anterior disc displacement with reduction.


Description:

Temporomandibular joint (TMJ) anterior disc displacement (ADD) is one of the most common TMJ disorders.It can occur in all age groups, with a high prevalence in adolescents . ADD often presents with clicking, joint pain, a limited range of mouth opening. Furthermore,ADD might lead to osteoarthrosis . Since ADD of the TMJ can lead to various harmful outcomes, how to manage ADD is considered a key problem for most TMJ experts. It has been difficult for most clinicians to select a suitable method for ADD patients with different grades of severitis ). Initially, these conditions can be managed conservatively by employing techniques such as occlusal splint therapy, physiotherapy, pharmacotherapy and occlusal treatments. If Medical treatment fails, minimally invasive (sodium hyaluronate or corticosteroid infiltrations and arthrocentesis) and invasive treatments (arthroscopy, arthroplasty, arthrotomy, discectomy, condylotomy) are formed ). Sodium hyaluronate is a buffered solution of hyaluronate acid sodium salt, which is an essential component of the cartilage.It acts against the disintegration of the extracellular matrix.It reduces friction, and it features an anti-inflamatory effect. It is indicated for the treatment of osteoarthritic symptoms and inflammatory degenerative joint disease). Intra-articular hyaluronic acid injection provides long-term palliative effects on symptoms and signs of TMJ pain .


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 42
Est. completion date August 2, 2024
Est. primary completion date August 1, 2024
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Adults with age between( 18-45) years - Both genders - The cases ciinically have either of ( limitation of mouth opening , pre-auricular pain , headache, temporal, and occipital tenderness ) and radiologically (MRI) diagnosed as ADD with reduction - The patients have symptom durations for more than 3 months with medical treatment. - Patients whom did not respond to medical treatment Exclusion Criteria: - Previous TMJ surgery or previous arthrocentesis. - Patients with arthritis or history of condylar trauma - Patients with degenerative change of the condylar head and with facial asymmetry, retrognathism, or prognathism - Severe co-morbid conditions (uncontrolled diabetes, Hypertenion

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
arthrocentesis alone
The procedure is done under general anesthesia. The patient is seated inclined at a 45 degree angle with the head turned to contralateral side. The points of needle insertion on the skin, are as follow: a line is drawn from the middle of the tragus to the outer canthus of the eye. The posterior entrance point is located along the canthotragal line, 10 mm from the middle of the tragus line and 2 mm below, the anterior entrance point is placed 10 mm further forward along the line and 10 mm below it . A needle connected to a 10 ml syringe with the Ringer's lactate solution is then inserted into the superior compartment (posterior point), and solution is injected . Another needle is then inserted into the area of articular eminence to enable the free flow of solution through the superior compartment. During the lavage, the mandible is moved through opening, excursive, and protrusive movements to facilitate lysis of adhesions
arthrocentesis with hyaluronic acid injection
in this group Once arthrocentesis is completed, an ampule of sodium HA (Hyalgan 1 ml) is connected to the needle in situ And 0.5 ml injected into the superior joint space. Pressure dressing is placed in site of injection. so We use arthrocentesis hyaluronic acid injection in management of temporomandibular joint dysfunction in the form of anterior disc displacement with reduction

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Outcome

Type Measure Description Time frame Safety issue
Primary Mouth opening Maximum inter-incisal opening (MIO): measured by Vernier caliper in millimeters (mm) as the vertical distance between the incisal edges of maxillary and mandibular central incisors. Preoperative and postoperative measurement of MIO would help in evaluation of improvement in mouth opening after arthrocentesis Three months
Primary Tempero mandibular joint pain Pain was assessed using visual analogue scale (VAS):
which ranges from zero to 10 (where zero refers to no pain, 1:3 mild pain, 4:6 moderate pain, 7:9 severe pain and 10 maximum pain) assessing pre and post operative will provide good evidence about effect of arthrocentesis in decrease Tempero mandibular joint pain
One month
Secondary Clicking Clicking was assessed as its presence or absence where zero refers to absence of clicking, 1 indicates decrease in sound and frequency of clicking, and 2 indicates presence of clicking.Assessment of clicking showed that there was statistically significant difference between the two groups along the evaluation intervals. There was statistically significant difference between clicking scores at the baseline when compared to the follow-up intervals within both groups Three months
See also
  Status Clinical Trial Phase
Recruiting NCT05006963 - Tele-Rehabilitation in Patients With Temporomandibular Dysfunction N/A
Completed NCT03596606 - Additional Effects of Therapeutic Exercises Under a Behavioral Umbrella for Chronic Temporomandibular Disorders Treatment N/A
Completed NCT06005922 - The Effectiveness of Temporomandibular Joint Mobilization and Exercise in Individuals With Chronic Neck Pain N/A
Completed NCT04477122 - Effects of Radial Shock Wave Therapy in the Treatment of Temporomandibular Joint Syndrome. N/A
Recruiting NCT06134310 - Efficacy of Manual Therapy Based on the Fascial Distortion Model in Individuals With Temporomandibular Disorder N/A
Completed NCT02295644 - Immediate Effect of Ultrasound Therapy on Bilateral Masseter Myalgia: Randomized Single Blinded Investigational Trial N/A
Completed NCT05901701 - Efficacy of Low Level LASER Therapy in Treating Temporomandibular Muscle Disorders N/A
Recruiting NCT05802953 - Quality of Life in Temporomandibular Joint Dysfunction
Recruiting NCT04831346 - Effects of Low-Level Laser Therapy on Mouth Opening and Surface Electromyography in Temporomandibular Disorders N/A
Completed NCT05893251 - Effectiveness of Cervical Treatment in Wind Musicians With Temporomandibular Dysfunction N/A
Completed NCT03036215 - Tailored Self-Management of Temporomandibular Disorders (TMD) Using Health Information Technology N/A
Completed NCT06141863 - Temporomandibular Dysfunction in Patients With Cervical Disc Herniation
Completed NCT01800279 - Physiotherapy and Deontology in the Temporomandibular Joint Dysfunction in Patients With Fibromyalgia Syndrome. N/A
Recruiting NCT00870922 - Effects of Masseter Manual Therapy on Temporomandibular Dysfunction Phase 1
Completed NCT03622684 - Progressive Muscle Relaxation According to Jacobson in Treatment of the Patients With Temporomandibular Joint Disorders N/A
Completed NCT03512769 - Feasibility Testing of a New Way to Support the Jaw During 3rd Molar Extractions
Withdrawn NCT01954511 - Manual Therapy and Exercises Applied to Cervical Spine in Patients With Temporomandibular Disorders N/A
Recruiting NCT04609748 - Comparative Analysis of the Effectiveness of the Use of Nimesulide and CBD Oil in Patients With Pain in the Preauricular Region Due to the Pain-dysfunctional Syndrome of the Temporomandibular Joint. Phase 2
Withdrawn NCT02202070 - Botox for Treatment of TMJ Disorder With Bruxism Phase 1
Terminated NCT00716807 - Efficacy of Nalbuphine and Naloxone Administered as Nose Sprays in the Treatment of Orofacial Pain N/A